DE69435138D1 - Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung - Google Patents

Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung

Info

Publication number
DE69435138D1
DE69435138D1 DE69435138T DE69435138T DE69435138D1 DE 69435138 D1 DE69435138 D1 DE 69435138D1 DE 69435138 T DE69435138 T DE 69435138T DE 69435138 T DE69435138 T DE 69435138T DE 69435138 D1 DE69435138 D1 DE 69435138D1
Authority
DE
Germany
Prior art keywords
extracellular products
vaccines
majorly abundant
methods
stimulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69435138T
Other languages
German (de)
English (en)
Inventor
Marcus A Horwitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/156,358 external-priority patent/US6752993B1/en
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Application granted granted Critical
Publication of DE69435138D1 publication Critical patent/DE69435138D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Multi-Process Working Machines And Systems (AREA)
  • Telephone Function (AREA)
  • Stringed Musical Instruments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69435138T 1993-11-23 1994-11-18 Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung Expired - Lifetime DE69435138D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/156,358 US6752993B1 (en) 1993-11-23 1993-11-23 Abundant extracellular product vaccines and methods for their production and use
US28966794A 1994-08-12 1994-08-12
PCT/US1994/013145 WO1995014713A2 (en) 1993-11-23 1994-11-18 Abundant extracellular products and methods for their production and use

Publications (1)

Publication Number Publication Date
DE69435138D1 true DE69435138D1 (de) 2008-10-23

Family

ID=26853097

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69435138T Expired - Lifetime DE69435138D1 (de) 1993-11-23 1994-11-18 Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung

Country Status (12)

Country Link
US (1) US6761894B1 (OSRAM)
EP (1) EP0771322B9 (OSRAM)
JP (2) JPH09505588A (OSRAM)
CN (1) CN1103781C (OSRAM)
AT (1) ATE407945T1 (OSRAM)
AU (1) AU1097795A (OSRAM)
BR (1) BR9408135A (OSRAM)
CA (1) CA2177249C (OSRAM)
DE (1) DE69435138D1 (OSRAM)
DK (1) DK0771322T3 (OSRAM)
ES (1) ES2313719T3 (OSRAM)
WO (1) WO1995014713A2 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
DK0771322T3 (da) 1993-11-23 2008-11-24 Univ California Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf
DE69529219T2 (de) * 1994-07-01 2003-11-06 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Helicobacter proteine und impstoffe
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
JPH11506320A (ja) * 1995-05-23 1999-06-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 豊富な細胞外産物、ならびにそれらを産生および使用するための方法
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
AU1463097A (en) * 1996-01-04 1997-08-01 Rican Limited Helicobacter pylori bacterioferritin
JP2001500004A (ja) * 1996-07-26 2001-01-09 アンスティテュ、パストゥール ヒト型結核菌（ｍｙｃｏｂａｃｔｅｒｉｕｍ ｔｕｂｅｒｃｕｌｏｓｉｓ）のデサチュレーション抗原
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
DE69838948T2 (de) * 1997-01-21 2008-10-02 The Regents Of The University Of California, Oakland Epitopen eines extrazellulären antigens
US6350456B1 (en) * 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6544522B1 (en) 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
CN101090974B (zh) 2004-11-16 2011-05-11 克鲁塞尔荷兰公司 包含重组病毒载体的多价疫苗
CN102850445B (zh) * 2012-09-24 2014-01-08 张银辉 一组结核分枝杆菌菌体特异性抗原及其纯化方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888837A (en) 1973-06-28 1975-06-10 Mitsui Pharmaceuticals Tuberculin active proteins and peptides from the cells of tubercle bacilli
AU5856073A (en) 1973-06-28 1975-01-30 Toru Tsumits Tuberculin active proteins and peptides
US4123427A (en) 1976-07-27 1978-10-31 Daniel Thomas M Method for the purification of mycobacterial protein antigens and resulting product
US4460503A (en) 1983-03-15 1984-07-17 Institut Pasteur Tuberculine active peptides and a process for preparing same by chemical synthesis
GB8404280D0 (en) 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4777130A (en) 1984-12-05 1988-10-11 Andra Biologicals Isolation of mycobacterial a 60 antigen for diagnostic purposes
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4906742A (en) 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
WO1988002027A1 (en) 1986-09-08 1988-03-24 Applied Biotechnology, Inc. Genetically engineered vaccines for mycobacteria
US5268170A (en) 1986-09-09 1993-12-07 Yeda Research And Development Co., Ltd. Methods of treatment and diagnosis of autoimmune diseases, especially arthritic conditions
WO1988005823A2 (en) 1987-02-02 1988-08-11 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis genes encoding protein antigens
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4976958A (en) 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5504005A (en) 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine
DE3854840D1 (de) 1987-03-02 1996-02-08 Whitehead Biomedical Inst Rekombinant-mykobakterielle impfstoffe
US5225324A (en) 1987-04-24 1993-07-06 Bioscience International, Inc. Diagnostics for mycobacteria in public health, medical, and veterinary practice
WO1989005825A1 (en) 1987-12-22 1989-06-29 Immunex Corporation EXPRESSION OF RECOMBINANT 18/16.6 AND 15.2 kD PROTEIN ANTIGENS OF MYCOBACTERIUM LEPRAE
NL8703107A (nl) 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
ATE127345T1 (de) 1988-06-15 1995-09-15 Whitehead Biomedical Inst Stressproteine und verwendungen dafür.
US5108745B1 (en) 1988-08-16 1998-06-30 Univ California Tuberculosis and legionellosis vaccines and methods for their production
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
JPH04506297A (ja) 1989-06-19 1992-11-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ ベクター媒介ゲノム挿入及びｂｃｇにおけるｄｎａの発現
IL95742A (en) * 1989-09-19 2000-12-06 Innogenetics Nv Recombinant polypeptides and peptides nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
SE9001105D0 (sv) 1990-03-27 1990-03-27 Astra Ab New methods foer diagnosis of tuberculosis
GB2239246A (en) 1989-12-22 1991-06-26 Astra Ab Protein antigen from Mycobacterium tuberculosis
CA2045842A1 (en) 1990-07-16 1992-01-17 William R. Jacobs Dna capable of site-specific integration into mycobacteria
GB9015888D0 (en) 1990-07-19 1990-09-05 Smithkline Biolog Vectors
US5254459A (en) 1990-08-23 1993-10-19 Patarroyo Manuel E Nucleotide and amino acid sequences of protein MTP40 of M. tuberculosis and synthetic peptides derived therefrom
US5171839A (en) 1990-08-23 1992-12-15 Patarroyo Manuel E Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
US5169940A (en) 1990-08-23 1992-12-08 Patarroyo Manuel E Nucleotide sequences of protein MTP40 of M. tuberculosis
CA2089488A1 (en) 1990-09-06 1993-03-07 Judy Lieberman Pathogen-specific ctl therapy
EP0499003A1 (en) * 1991-02-14 1992-08-19 N.V. Innogenetics S.A. Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
DE69231519T2 (de) 1991-03-25 2001-05-31 N.V. Innogenetics S.A., Gent Polypeptide aus micobakterium paratuberculosis
GB9111291D0 (en) 1991-05-24 1991-07-17 Medical Res Council Diagnostic peptides
CA2110682A1 (en) 1991-06-06 1992-12-10 Charles K. Stover Induction of ctl responses to foreign antigens expressed in mycobacteria
FR2677365B1 (fr) 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
EP0972839A1 (en) 1991-06-13 2000-01-19 ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, a division of YESHIVA UNIVERSITY Insertional mutations in mycobacteria
AU681572B2 (en) 1991-10-21 1997-09-04 Med Immune, Inc. Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
FR2682967B1 (fr) 1991-10-25 1994-01-14 Pasteur Institut Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.
GB9200949D0 (en) 1992-01-17 1992-03-11 Medical Res Council Diagnostic peptides
WO1993014789A1 (en) 1992-01-22 1993-08-05 New England Medical Center Hospitals, Inc. Pathogen-specific ctl therapy
FR2687410A1 (fr) 1992-02-14 1993-08-20 Pasteur Institut Beta-lactamase recombinante, utilisable en tant que molecule porteuse pour la preparation de compositions immunogenes.
FR2688785B1 (fr) 1992-03-19 1995-07-07 Pasteur Institut Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.
WO1994002508A2 (en) 1992-07-22 1994-02-03 Proteus Molecular Design Limited Polypeptide antigens of mycobacterium bovis
DK79793D0 (da) 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
DK79893D0 (da) 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK0771322T3 (da) 1993-11-23 2008-11-24 Univ California Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf

Also Published As

Publication number Publication date
BR9408135A (pt) 1997-08-05
JPH09505588A (ja) 1997-06-03
EP0771322A1 (en) 1997-05-07
JP2005104983A (ja) 2005-04-21
ES2313719T3 (es) 2009-03-01
US6761894B1 (en) 2004-07-13
EP0771322B1 (en) 2008-09-10
ATE407945T1 (de) 2008-09-15
AU1097795A (en) 1995-06-13
CA2177249C (en) 2010-10-19
CA2177249A1 (en) 1995-06-01
CN1142231A (zh) 1997-02-05
JP4537178B2 (ja) 2010-09-01
WO1995014713A3 (en) 1995-12-28
EP0771322B9 (en) 2009-08-12
DK0771322T3 (da) 2008-11-24
WO1995014713A2 (en) 1995-06-01
CN1103781C (zh) 2003-03-26

Similar Documents

Publication Publication Date Title
DE69435138D1 (de) Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung
CA2050749A1 (en) Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
BR9906927A (pt) Proteìnas de neisseria meningitidis
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
DE69229476D1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
ATE71660T1 (de) Autonome replikationssequenzen fuer hefestaemme des genus pichia.
BR9608894A (pt) Produtos extracelulares abundantes e processos para suas producões e usos
EP1005365A4 (en) ABUNDANT EXTRACELLULAR PRODUCTS AND METHODS OF PRODUCING AND USING THE SAME
BR9712556A (pt) Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
AU2529095A (en) Vaccine against mycobacterial infections
WO1997044463A3 (fr) Identification et clonage d'un antigene mycobacterien correspondant a une hemagglutinine de liaison a l'heparine
DE69408135D1 (de) Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene
WO2003086277A3 (en) Attenuated gram negative bacteria
DE69836520D1 (de) Clostridium perfringens Impfstoff
WO2004103269A3 (en) Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
AP1502A (en) Genes and proteins, and their uses.
WO2004024756A3 (en) Orthopoxvirus antigens and use thereof
WO2005027844A3 (en) Dna vaccine compositions and methods of use
MX9701103A (es) Productos extracelulares abundantes y metodos para su produccion y uso.
ATE246002T1 (de) Membranproteine von leptospira
WO2000047227A3 (en) Mycobacterium tuberculosis, immunization
WO2004045548A3 (en) Genetic constructs and compositions comprising rre and cte and uses thereof
WO2024173724A3 (en) P36 and p52 as protective malaria vaccine antigens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition